Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2026-01-19 @ 1:30 PM
Study NCT ID:
NCT00112359
Status:
COMPLETED
Last Update Posted:
2011-04-21
First Post:
2005-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Sponsor:
Gilead Sciences
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CP-AI-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mark Bresnik, MD, Director, Clinical Research
Old Organization:
Gilead Sciences, Inc.